Former HISD Alumni Spark the Need for After-School Programs and the need for more Alumni Teacher's and administrators in the United States: A TEDxSunnysideED Talk by Amber Newman Read more about Former HISD Alumni Spark the Need for After-School Programs and the need for more Alumni Teacher's and administrators in the United States: A TEDxSunnysideED Talk by Amber Newman
'It's a special place': Tebow partners with second-chance Cincinnati manufacturer Read more about 'It's a special place': Tebow partners with second-chance Cincinnati manufacturer
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development Read more about Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
EVLV INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Read more about EVLV INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
EVLV INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors with Substantial Losses Have Opportunity to Lead the Evolv Class Action Lawsuit Read more about EVLV INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors with Substantial Losses Have Opportunity to Lead the Evolv Class Action Lawsuit
Synthekine Announces U.S. FDA Clearance of IND Application for CD19 CAR-T and Orthogonal IL-2 Combination Therapy, SYNCAR-001 + STK-009, for Treatment of Lupus Without Lymphodepletion Read more about Synthekine Announces U.S. FDA Clearance of IND Application for CD19 CAR-T and Orthogonal IL-2 Combination Therapy, SYNCAR-001 + STK-009, for Treatment of Lupus Without Lymphodepletion
Parkland parent voices support for shooting home intruders: 'Based' Read more about Parkland parent voices support for shooting home intruders: 'Based'
Parkland parent voices support for shooting home intruders: 'Based' Read more about Parkland parent voices support for shooting home intruders: 'Based'
Parkland parent voices support for shooting home intruders: 'Based' Read more about Parkland parent voices support for shooting home intruders: 'Based'
Parkland parent voices support for shooting home intruders: 'Based' Read more about Parkland parent voices support for shooting home intruders: 'Based'